Loading...

IM Cannabis Corp.

IMCC.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$5.10
CA$-3.40(-40.00%)

IM Cannabis Corp. (IMCC.CN) Stock Overview

Explore IM Cannabis Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap17.2M
P/E Ratio-1.49
EPS (TTM)$-1.90
ROE-1.52%
Fundamental Analysis

AI Price Forecasts

1 Week$6.10
1 Month$5.36
3 Months$0.00
1 Year Target$1.23

IMCC.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IM Cannabis Corp. (IMCC.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.49 and a market capitalization of 17.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

60.61RSI (14)
0.90MACD
60.49ADX
Revenue Growth
10.71%
↑ 10.71%
Profit Growth
CA$-3.43
↓ 11.44%
EPS Growth
CA$-3.43
↓ 6.52%
Operating Margin
-50.44%
↑ 15.94%
ROE
-152.40%
↓ 11.44%
Dividend Yield
0.00%
Analyst Recommendations data is not available for IMCC.CNAnalyst Recommendations details for IMCC.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

CEO

Oren Shuster

Employees

95

Headquarters

Kibbutz Glil Yam, Tel Aviv

Founded

1996

Frequently Asked Questions

;